All articles tagged with #jurickson profar
Jurickson Profar has been suspended for the entire 2026 regular season and postseason after failing a PED test; the MLBPA's appeal did not overturn the ruling. The Braves now have about $18 million to spend and Profar will not play in 2026, with his future with the team uncertain.
Jurickson Profar tested positive for performance-enhancing drugs for a second time and was suspended, making him ineligible for the World Baseball Classic and forcing Team Netherlands to scramble minutes before their game; while Profar appeals, replacements Ray-Patrick Didder and Jakey Josepha were added, with Didder delivering a leadoff homer in his first at-bat as the team moves on.
World Baseball Classic kicks off in Tokyo with notable rosters as the 2026 season looms; Jurickson Profar faces a 162-game PED suspension and Johan Rojas reportedly faces an 80-game ban, both likely to be appealed, leaving the Braves and Phillies reworking Opening Day plans. Profar’s absence could free payroll and create DH/outfield vacancies, prompting potential adds such as Lucas Giolito or Zack Littell and a bat like Dominic Smith, Ben Gamel, or Tristin English for Atlanta, while injuries to Schwellenbach and Waldrep strain depth. Philadelphia will lean on top prospect Justin Crawford with Pedro León and Bryan De La Cruz in the mix for outfield depth. The interplay of WBC action and suspensions could reshape NL East plans ahead of opening day.
Tim Dierkes’ MLB Mailbag debates how the Braves fill Jurickson Profar’s PED suspension, weighing payroll flexibility, one-year adds (like Giolito or Littell) or trades, and even the possibility of cutting Profar; it also highlights Eli White as a potential Yaz platoon partner, notes the White Sox’s infield depth, and covers the Mariners’ rotation depth along with other reader questions.
Braves outfielder Jurickson Profar has been handed a 162-game suspension for testing positive for a performance‑enhancing drug, likely sidelining him for the 2026 season and forcing the team to explore internal and external options to fill the outfield. The Players Association plans to challenge the suspension, and the grievance process could delay any ban as MLB’s drug program reviews the case. The piece also notes other MLB PED suspensions and related roster considerations.
The Atlanta Braves released an official statement expressing disappointment in Jurickson Profar’s 162-game suspension for a second PED positive and reaffirmed their support for MLB’s Drug Prevention and Treatment Program. The suspension, which begins March 6, 2026, comes after Profar previously missed 80 games this season; the Braves will not pay his 2026 salary or payroll taxes and he remains ineligible for postseason. ESPN’s Jeff Passan broke the news, and MLB issued its own statement confirming the ban.
MLB suspended Braves outfielder Jurickson Profar for 162 games after a second PED violation (exogenous testosterone); the penalty begins Friday, and the Players Association plans an expedited appeal. Second offenses can be appealed but carry no stay, while first-time penalties are stayed during appeal. Profar previously missed 80 games in 2025 for hCG. The Braves face roster and luxury-tax implications as they move into 2026 without him.
Braves outfielder Jurickson Profar has been suspended 162 games for a second PED violation, ending his 2026 season and making him ineligible for the World Baseball Classic; the team now faces DH lineup questions as spring training approaches.
Atlanta Braves utility player Jurickson Profar could receive a 162-game suspension for a second positive drug test, AP sources say, a penalty that would sideline him for the entire season; the report notes his spring training activity as the case unfolds.
Braves outfielder Jurickson Profar faces a 162-game suspension for a second PED violation, with MLB and the union likely to pursue a grievance to an independent arbitrator. If imposed, he would miss the season and postseason and forfeit about $15 million of this year’s $42 million contract; Profar previously served an 80-game ban for hCG, and Atlanta must navigate his absence as spring training continues and replacements are considered.
Jurickson Profar reportedly faces a full-season 162-game suspension for PED usage, leaving the Braves without a key contributor in 2026 as the MLBPA plans a grievance on the move.
Jurickson Profar faces a 162-game PED suspension, his second failed test, which would erase the 2026 season, postseason eligibility, and WBC participation; the MLBPA plans to challenge the ruling. The 33-year-old was already suspended for 80 games last year and would incur a lifetime ban on a third positive test. Under a three-year, $42M Braves contract, he won’t be paid this season and could be placed on the restricted list, saving Atlanta roughly $18M in payroll/tax. The Braves’ outfield and rotation could be reshaped as they balance the suspension with injuries to pitchers and potential in-season additions, aided by Mike Yastrzemski and a core group including Harris II and Acuña Jr. Changes in the roster and payroll strategy are anticipated as the team evaluates next steps.
This article provides a weekly guide for fantasy baseball managers on top waiver wire pickups and drops, highlighting players like Jurickson Profar returning from suspension, Jacob Lopez's recent strong performances, and recommended pitchers to stream based on roster percentages and matchups.
The San Diego Padres are planning to inform Xander Bogaerts of his 2025 position earlier than last year, likely returning him to shortstop. They hope Luis Arraez can improve his on-base percentage while maintaining his batting prowess. Jurickson Profar is testing free agency, making his return to the Padres uncertain due to potential high contract demands. The team is also exploring trade options to manage payroll and is interested in Japanese pitcher Roki Sasaki, among others, as they assess their roster needs for the upcoming season.
Jurickson Profar has emerged as a key player for the San Diego Padres, significantly outperforming expectations with a .323/.421/.495 batting line and solidifying the outfield alongside Fernando Tatis Jr. and Jackson Merrill. Despite payroll constraints and initial skepticism, Profar's performance has been a major asset, making him one of the top contributors in the National League and potentially setting him up for a lucrative free agency next offseason.